HomeMRSN • NASDAQ
add
Mersana Therapeutics Inc
Previous close
$0.46
Day range
$0.43 - $0.45
Year range
$0.43 - $5.11
Market cap
50.85M USD
Avg Volume
3.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 16.36M | 52.89% |
Operating expense | 8.89M | -12.31% |
Net income | -14.12M | 27.77% |
Net profit margin | -86.28 | 52.76% |
Earnings per share | -0.11 | 30.38% |
EBITDA | -14.41M | 29.64% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 134.62M | -35.61% |
Total assets | 144.66M | -36.01% |
Total liabilities | 154.17M | -18.49% |
Total equity | -9.51M | — |
Shares outstanding | 124.63M | — |
Price to book | -5.74 | — |
Return on assets | -23.57% | — |
Return on capital | -143.19% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -14.12M | 27.77% |
Cash from operations | -19.25M | 39.77% |
Cash from investing | 50.00M | 148.16% |
Cash from financing | -1.87M | -2,129.35% |
Net change in cash | 28.88M | 346.39% |
Free cash flow | -10.01M | 19.61% |
About
Founded
2001
Website
Employees
102
